Inhibition of intestinal Lactobacilli and reversed Firmicutes/Bacteroides ratio upon treatment with tempol (an anti-oxidant that reduces obesity in mice) led to increased T-β-MCA accumulation that inhibited intestinal FXR activity leading to decreased obesity in mice [170]. This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.